{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T07:00:01Z","timestamp":1791874801685,"version":"4.3.4"},"reference-count":183,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,9,8]],"date-time":"2022-09-08T00:00:00Z","timestamp":1662595200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell Dev. Biol."],"abstract":"<jats:p>Cachexia is a devastating syndrome associated with the end-stage of several diseases, including cancer, and characterized by body weight loss and severe muscle and adipose tissue wasting. Although different cancer types are affected to diverse extents by cachexia, about 80% of all cancer patients experience this comorbidity, which highly reduces quality of life and response to therapy, and worsens prognosis, accounting for more than 25% of all cancer deaths. Cachexia represents an urgent medical need because, despite several molecular mechanisms have been identified, no effective therapy is currently available for this devastating syndrome. Most studies focus on skeletal muscle, which is indeed the main affected and clinically relevant organ, but cancer cachexia is characterized by a multiorgan failure. In this review, we focus on the current knowledge on the multiple tissues affected by cachexia and on the biomarkers with the attempt to define a chronological pathway, which might be useful for the early identification of patients who will undergo cachexia. Indeed, it is likely that the inefficiency of current therapies might be attributed, at least in part, to their administration in patients at the late stages of cachexia.<\/jats:p>","DOI":"10.3389\/fcell.2022.960341","type":"journal-article","created":{"date-parts":[[2022,9,8]],"date-time":"2022-09-08T03:19:31Z","timestamp":1662607171000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":45,"title":["Cancer cachexia as a multiorgan failure: Reconstruction of the crime scene"],"prefix":"10.3389","volume":"10","author":[{"given":"Michele","family":"Ferrara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Samaden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Ruggieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie","family":"V\u00e9n\u00e9reau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,9,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e102436","DOI":"10.1371\/journal.pone.0102436","article-title":"Tocilizumab, a proposed therapy for the cachexia of interleukin6-expressing lung cancer","volume":"9","author":"Ando","year":"2014","journal-title":"PLoS ONE"},{"key":"B2","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s13395-019-0209-y","article-title":"Immunohistochemical phenotyping of T cells, granulocytes, and phagocytes in the muscle of cancer patients: Association with radiologically defined muscle mass and gene expression","volume":"9","author":"Anoveros-Barrera","year":"2019","journal-title":"Skelet. Muscle"},{"key":"B3","doi-asserted-by":"publisher","first-page":"92","DOI":"10.3389\/fphys.2017.00092","article-title":"Validation of the CAchexia SCOre (CASCO). Staging cancer patients: The use of miniCASCO as a simplified tool","volume":"8","author":"Argil\u00e9s","year":"2017","journal-title":"Front. Physiol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1038\/nrc3829","article-title":"Cancer cachexia: Understanding the molecular basis","volume":"14","author":"Argil\u00e9s","year":"2014","journal-title":"Nat. Rev. Cancer"},{"key":"B5","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1615\/critrevoncog.v17.i3.30","article-title":"Counteracting inflammation: A promising therapy in cachexia","volume":"17","author":"Argil\u00e9s","year":"2012","journal-title":"Crit. Rev. Oncog."},{"key":"B6","doi-asserted-by":"publisher","first-page":"7960","DOI":"10.4081\/ejtm.2019.7960","article-title":"Therapeutic strategies against cancer cachexia","volume":"29","author":"Argil\u00e9s","year":"","journal-title":"Eur. J. Transl. Myol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s13539-011-0027-5","article-title":"The cachexia score (CASCO): A new tool for staging cachectic cancer patients","volume":"2","author":"Argil\u00e9s","year":"2011","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"B8","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41574-018-0123-0","article-title":"Inter-tissue communication in cancer cachexia","volume":"15","author":"Argil\u00e9s","year":"","journal-title":"Nat. Rev. Endocrinol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1002\/ijc.24784","article-title":"Evidence for the contribution of insulin resistance to the development of cachexia in tumor-bearing mice","volume":"126","author":"Asp","year":"2010","journal-title":"Int. J. Cancer"},{"key":"B10","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1186\/1471-2407-10-363","article-title":"Molecular, cellular and physiological characterization of the cancer cachexia-inducing C26 colon carcinoma in mouse","volume":"10","author":"Aulino","year":"2010","journal-title":"BMC Cancer"},{"key":"B11","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/s41577-021-00624-w","article-title":"The interplay of immunology and cachexia in infection and cancer","volume":"22","author":"Baazim","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/s41590-019-0397-y","article-title":"CD8+ T cells induce cachexia during chronic viral infection","volume":"20","author":"Baazim","year":"2019","journal-title":"Nat. Immunol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1097\/SPC.0000000000000233","article-title":"Animal models for cancer cachexia","volume":"10","author":"Ballar\u00f2","year":"2016","journal-title":"Curr. Opin. Support. Palliat. Care"},{"key":"B14","doi-asserted-by":"publisher","first-page":"R393","DOI":"10.1152\/ajpregu.00716.2007","article-title":"Interleukin-6 and cachexia in ApcMin\/+ mice","volume":"294","author":"Baltgalvis","year":"2008","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"17105","DOI":"10.1038\/nrdp.2017.105","article-title":"Cancer-associated cachexia","volume":"4","author":"Baracos","year":"2018","journal-title":"Nat. Rev. Dis. Prim."},{"key":"B16","doi-asserted-by":"publisher","first-page":"7535","DOI":"10.1038\/s41598-020-64282-z","article-title":"An elevated neutrophil-to-lymphocyte ratio associates with weight loss and cachexia in cancer","volume":"10","author":"Barker","year":"2020","journal-title":"Sci. Rep."},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1002\/ehf2.12184","article-title":"Cardiac muscle wasting in individuals with cancer cachexia\u201d","volume":"4","author":"Barkhudaryan","year":"2017","journal-title":"Esc. Heart Fail."},{"key":"B18","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/s0039-6060(05)80014-5","article-title":"Reversal of tumor-associated hyperglucagonemia as treatment for cancer cachexia","volume":"118","author":"Bartlett","year":"1995","journal-title":"Surgery"},{"key":"B19","doi-asserted-by":"publisher","first-page":"e37971","DOI":"10.1371\/journal.pone.0037971","article-title":"Restoring specific lactobacilli levels decreases inflammation and muscle atrophy markers in an acute leukemia mouse model","volume":"7","author":"Bindels","year":"2012","journal-title":"PLoS ONE"},{"key":"B20","doi-asserted-by":"publisher","first-page":"18224","DOI":"10.18632\/oncotarget.24804","article-title":"Increased gut permeability in cancer cachexia: Mechanisms and clinical relevance","volume":"9","author":"Bindels","year":"2018","journal-title":"Oncotarget"},{"key":"B21","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.yclnex.2015.11.001","article-title":"Nutrition in cancer patients with cachexia: A role for the gut microbiota?","volume":"6","author":"Bindels","year":"2016","journal-title":"Clin. Nutr. Exp."},{"key":"B22","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1146\/annurev-cancerbio-030419-033642","article-title":"Cancer-associated cachexia: A systemic consequence of cancer progression","volume":"4","author":"Biswas","year":"2020","journal-title":"Annu. Rev. Cancer Biol."},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3791\/54893","article-title":"The colon-26 carcinoma tumor-bearing mouse as a model for the study of cancer cachexia","author":"Bonetto","year":"2016","journal-title":"J. Vis. Exp."},{"key":"B24","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.neuropharm.2017.12.024","article-title":"Brainstem GLP-1 signalling contributes to cancer anorexia-cachexia syndrome in the rat","volume":"131","author":"Borner","year":"2018","journal-title":"Neuropharmacology"},{"key":"B25","doi-asserted-by":"publisher","first-page":"3572","DOI":"10.1096\/fj.13-230375","article-title":"Cancer- and endotoxin-induced cachexia require intact glucocorticoid signaling in skeletal muscle","volume":"27","author":"Braun","year":"2013","journal-title":"FASEB J."},{"key":"B26","doi-asserted-by":"publisher","first-page":"e106489","DOI":"10.1371\/journal.pone.0106489","article-title":"Muscle atrophy in response to cytotoxic chemotherapy is dependent on intact glucocorticoid signaling in skeletal muscle","volume":"9","author":"Braun","year":"2014","journal-title":"PLoS ONE"},{"key":"B27","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1084\/jem.20111020","article-title":"Central nervous system inflammation induces muscle atrophy via activation of the hypothalamic-pituitary-adrenal axis","volume":"208","author":"Braun","year":"2011","journal-title":"J. Exp. Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1016\/j.cmet.2020.10.023","article-title":"GDF-15 neutralization alleviates platinum-based chemotherapy-induced emesis, anorexia, and weight loss in mice and nonhuman primates","volume":"32","author":"Breen","year":"2020","journal-title":"Cell Metab."},{"key":"B29","doi-asserted-by":"publisher","first-page":"e54095","DOI":"10.7554\/eLife.54095","article-title":"Circulating myeloid cells invade the central nervous system to mediate cachexia during pancreatic cancer","volume":"9","author":"Burfeind","year":"2020","journal-title":"eLife"},{"key":"B30","doi-asserted-by":"publisher","first-page":"E700","DOI":"10.1210\/jc.2011-2387","article-title":"Low testosterone levels and increased inflammatory markers in patients with cancer and relationship with cachexia","volume":"97","author":"Burney","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B31","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1002\/rco2.30","article-title":"Mediators and clinical treatment for cancer cachexia: A systematic review","volume":"4","author":"Cao","year":"2021","journal-title":"JCSM Rapid Commun."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.3390\/cancers14071814","article-title":"Apelin resistance contributes to muscle loss during cancer cachexia in mice","volume":"14","author":"Cecconi","year":"2022","journal-title":"Cancers"},{"key":"B33","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1002\/jcsm.12023","article-title":"Ghrelin prevents tumour-and cisplatin-induced muscle wasting: Characterization of multiple mechanisms involved","volume":"6","author":"Chen","year":"2015","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"B34","doi-asserted-by":"publisher","first-page":"e2106868118","DOI":"10.1073\/pnas.2106868118","article-title":"Activation of the hypothalamic-pituitary-adrenal axis by exogenous and endogenous GDF15","volume":"118","author":"Cimino","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B35","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/nrd4467","article-title":"Muscle wasting in disease: Molecular mechanisms and promising therapies","volume":"14","author":"Cohen","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"B36","doi-asserted-by":"publisher","first-page":"E1242","DOI":"10.3390\/ijms21041242","article-title":"Cisplatin-induced skeletal muscle dysfunction: Mechanisms and counteracting therapeutic strategies","volume":"21","author":"Conte","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B37","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1002\/jcsm.12900","article-title":"Physical exercise at the crossroad between muscle wasting and the immune system: Implications for lung cancer cachexia","volume":"13","author":"Cortiula","year":"2022","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1002\/jcsm.12449","article-title":"Cancer cachexia induces morphological and inflammatory changes in the intestinal mucosa","volume":"10","author":"Costa","year":"2019","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"B39","doi-asserted-by":"publisher","first-page":"6111","DOI":"10.4049\/jimmunol.1302895","article-title":"Novel role for tumor-induced expansion of myeloid-derived cells in cancer cachexia","volume":"192","author":"Cuenca","year":"2014","journal-title":"J. Immunol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"789889","DOI":"10.3389\/fmolb.2022.789889","article-title":"Metabolomics and its applications in cancer cachexia","volume":"9","author":"Cui","year":"2022","journal-title":"Front. Mol. Biosci."},{"key":"B41","doi-asserted-by":"publisher","first-page":"7590","DOI":"10.4081\/ejtm.2018.7590","article-title":"Chemotherapy-induced muscle wasting: Association with NF-\u03baB and cancer cachexia.","volume":"28","author":"Damrauer","year":"2018","journal-title":"Eur. J. Transl. Myol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1038\/s41586-018-0235-7","article-title":"Altered exocrine function can drive adipose wasting in early pancreatic cancer","volume":"558","author":"Danai","year":"2018","journal-title":"Nature"},{"key":"B43","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1126\/science.1205405","article-title":"Phosphorylation of the autophagy receptor optineurin restricts Salmonella growth.","volume":"333","author":"Das","year":"2011","journal-title":"Science"},{"key":"B44","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.1007\/s00125-015-3712-7","article-title":"Gut microorganisms as promising targets for the management of type 2 diabetes","volume":"58","author":"Delzenne","year":"2015","journal-title":"Diabetologia"},{"key":"B45","doi-asserted-by":"publisher","first-page":"ii18","DOI":"10.1093\/annonc\/mdx815","article-title":"Insulin resistance and body composition in cancer patients","volume":"29","author":"Dev","year":"2018","journal-title":"Ann. Oncol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"257","DOI":"10.3389\/fcell.2020.00257","article-title":"Non-coding RNAs as putative biomarkers of cancer-associated cachexia","volume":"8","author":"Donzelli","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.jhep.2010.08.012","article-title":"Efficiency of oxidative phosphorylation in liver mitochondria is decreased in a rat model of peritoneal carcinosis","volume":"54","author":"Dumas","year":"2011","journal-title":"J. Hepatol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"5280","DOI":"10.3390\/nu6115280","article-title":"Evidence and mechanisms of fat depletion in cancer","volume":"6","author":"Ebadi","year":"2014","journal-title":"Nutrients"},{"key":"B49","doi-asserted-by":"publisher","first-page":"820934","DOI":"10.1155\/2015\/820934","article-title":"Potential biomarkers of fat loss as a feature of cancer cachexia\u201d","author":"Ebadi","year":"2015","journal-title":"Mediat. Inflamm."},{"key":"B50","doi-asserted-by":"publisher","first-page":"287457","DOI":"10.1155\/2012\/287457","article-title":"Leptin in anorexia and cachexia syndrome","author":"Engineer","year":"2012","journal-title":"Int. J. Pept."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1002\/jcsm.12450","article-title":"Macrophages protect against loss of adipose tissue during cancer cachexia","volume":"10","author":"Erdem","year":"2019","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"B52","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s13765-019-0417-5","article-title":"Potential role of immunological factors in early diagnosis of cancer cachexia in C26 tumor-bearing mice","volume":"62","author":"Eun Ju","year":"2019","journal-title":"Appl. Biol. Chem."},{"key":"B53","first-page":"3347","article-title":"Limited impact of total parenteral nutrition on nutritional status during treatment for small cell lung cancer","volume":"45","author":"Evans","year":"1985","journal-title":"Cancer Res."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.3892\/or_00000581","article-title":"Impaired immune function: An early marker for cancer cachexia\u201d","volume":"22","author":"Faber","year":"2009","journal-title":"Oncol. Rep."},{"key":"B55","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1097\/00000658-199404000-00001","article-title":"Cytokines, the acute-phase response, and resting energy expenditure in cachectic patients with pancreatic cancer","volume":"219","author":"Falconer","year":"1994","journal-title":"Ann. Surg."},{"key":"B56","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1007\/pl00012351","article-title":"Pancreatic cancer as a model: Inflammatory mediators, acute-phase response, and cancer cachexia","volume":"23","author":"Fearon","year":"1999","journal-title":"World J. Surg."},{"key":"B57","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.cmet.2012.06.011","article-title":"Cancer cachexia: Mediators, signaling, and metabolic pathways","volume":"16","author":"Fearon","year":"2012","journal-title":"Cell Metab."},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/S1470","article-title":"Definition and classification of cancer cachexia: An international consensus","volume":"12","author":"Fearon","year":"2011","journal-title":"Lancet"},{"key":"B59","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1002\/jcsm.12798","article-title":"Bile acid metabolism dysregulation associates with cancer cachexia: Roles of liver and gut microbiome","volume":"12","author":"Feng","year":"2021","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"B60","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.devcel.2015.03.001","article-title":"Malignant drosophila tumors interrupt insulin signaling to induce cachexia-like wasting","volume":"33","author":"Figueroa-Clarevega","year":"2015","journal-title":"Dev. Cell"},{"key":"B61","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1038\/nm.4093","article-title":"Excessive fatty acid oxidation induces muscle atrophy in cancer cachexia","volume":"22","author":"Fukawa","year":"2016","journal-title":"Nat. Med."},{"key":"B62","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1002\/jcsm.12910","article-title":"Addressing unmet needs for people with cancer cachexia: Recommendations from a multistakeholder workshop","volume":"13","author":"Garcia","year":"2022","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"B63","doi-asserted-by":"publisher","first-page":"3118","DOI":"10.1210\/en.2013-1179","article-title":"Inhibition of cisplatin-induced lipid catabolism and weight loss by ghrelin in male mice","volume":"154","author":"Garcia","year":"2013","journal-title":"Endocrinology"},{"key":"B64","doi-asserted-by":"publisher","first-page":"90","DOI":"10.3390\/cancers14010090","article-title":"Aging aggravates cachexia in tumor-bearing mice\u201d","volume":"14","author":"Geppert","year":"2021","journal-title":"Cancers"},{"key":"B65","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.1089\/ars.2011.3965","article-title":"Chemotherapy-induced weakness and fatigue in skeletal muscle: The role of oxidative stress","volume":"15","author":"Gilliam","year":"2011","journal-title":"Antioxid. Redox Signal."},{"key":"B66","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1016\/j.clnu.2018.09.023","article-title":"Liver lipid metabolism disruption in cancer cachexia is aggravated by cla supplementation-induced inflammation","volume":"38","author":"Gon\u00e7alves","year":"2019","journal-title":"Clin. Nutr."},{"key":"B67","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1136\/gut.2004.047563","article-title":"Thalidomide in the treatment of cancer cachexia: A randomised placebo controlled trial","volume":"54","author":"Gordon","year":"2005","journal-title":"Gut"},{"key":"B68","doi-asserted-by":"publisher","first-page":"2339","DOI":"10.1200\/JCO.2005.02.345","article-title":"Prognostic role of interleukin-1beta gene and interleukin-1 receptor antagonist gene polymorphisms in patients with advanced gastric cancer.","volume":"23","author":"Graziano","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/B978-0-12-410473-0.00003-9","article-title":"The role of ghrelin in anorexia-cachexia syndromes","volume":"92","author":"Guillory","year":"2013","journal-title":"Vitam. Horm."},{"key":"B70","doi-asserted-by":"publisher","first-page":"E6267","DOI":"10.3390\/ijms20246267","article-title":"The microbiota and cancer cachexia","volume":"20","author":"Herremans","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"B71","doi-asserted-by":"publisher","first-page":"623","DOI":"10.3892\/ol.2018.9614","article-title":"Genetic influence of cytokine polymorphisms on the clinical outcome of Japanese gastrointestinal cancer patients in palliative care","volume":"17","author":"Hishida","year":"2019","journal-title":"Oncol. Lett."},{"key":"B72","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s13539-011-0051-5","article-title":"The role of insulin resistance in the development of muscle wasting during cancer cachexia","volume":"3","author":"Honors","year":"2012","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"B73","doi-asserted-by":"publisher","first-page":"12552","DOI":"10.1038\/s41598-017-12644-5","article-title":"Ginsenosides Rb3 and Rd reduce polyps formation while reinstate the dysbiotic gut microbiota and the intestinal microenvironment in Apc Min\/+ mice","volume":"7","author":"Huang","year":"2017","journal-title":"Sci. Rep."},{"key":"B74","doi-asserted-by":"publisher","first-page":"e0205467","DOI":"10.1371\/journal.pone.0205467","article-title":"Muscle regeneration is disrupted by cancer cachexia without loss of muscle stem cell potential","volume":"13","author":"Inaba","year":"2018","journal-title":"PLoS ONE"},{"key":"B75","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1042\/cs1020353","article-title":"Skeletal muscle mRNA levels for cathepsin B, but not components of the ubiquitin-proteasome pathway, are increased in patients with lung cancer referred for thoracotomy","volume":"102","author":"Jagoe","year":"2002","journal-title":"Clin. Sci. (Lond)."},{"key":"B76","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1089\/jir.2013.0020","article-title":"The altered tight junctions: An important gateway of bacterial translocation in cachexia patients with advanced gastric cancer","volume":"34","author":"Jiang","year":"2014","journal-title":"J. Interferon Cytokine Res."},{"key":"B77","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1016\/j.cell.2015.08.031","article-title":"Targeting of Fn14 prevents cancer-induced cachexia and prolongs survival","volume":"162","author":"Johnston","year":"2015","journal-title":"Cell"},{"key":"B78","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1002\/emmm.201201869","article-title":"TSC22D4 is a molecular output of hepatic wasting metabolism","volume":"5","author":"Jones","year":"2012","journal-title":"EMBO Mol. Med."},{"key":"B79","doi-asserted-by":"publisher","first-page":"pky043","DOI":"10.1093\/jncics\/pky043","article-title":"Skeletal muscle fibrosis in pancreatic cancer patients with respect to survival","volume":"2","author":"Judge","year":"2019","journal-title":"JNCI Cancer Spectr."},{"key":"B80","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1002\/jcsm.12346","article-title":"Tumour-derived leukaemia inhibitory factor is a major driver of cancer cachexia and morbidity in C26 tumour-bearing mice","volume":"9","author":"Kandarian","year":"2018","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"B81","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.pan.2016.01.006","article-title":"Metabolic effect of pancreatoduodenectomy: Resolution of diabetes mellitus after surgery","volume":"16","author":"Kang","year":"2016","journal-title":"Pancreatology"},{"key":"B82","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1096\/fasebj.2020.34.s1.09546","article-title":"Microglia contribute to cancer cachexia through affecting PVN neurons and POMC neurons","volume":"34","author":"Kashihara","year":"2020","journal-title":"FASEB J."},{"key":"B83","doi-asserted-by":"publisher","first-page":"879897","DOI":"10.1155\/2014\/879897","article-title":"Increased levels of granulocytic myeloid-derived suppressor cells in peripheral blood and tumour tissue of pancreatic cancer patients","author":"Khaled","year":"2014","journal-title":"J. Immunol. Res."},{"key":"B84","doi-asserted-by":"publisher","first-page":"CD012229","DOI":"10.1002\/14651858.CD012229.pub2","article-title":"Ghrelin for the management of cachexia associated with cancer","volume":"2","author":"Khatib","year":"2018","journal-title":"Cochrane Database Syst. Rev."},{"key":"B85","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.cmet.2015.11.003","article-title":"PTH\/PTHrP receptor mediates cachexia in models of kidney failure and cancer","volume":"23","author":"Kir","year":"2016","journal-title":"Cell Metab."},{"key":"B86","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/nature13528","article-title":"Tumour-derived PTH-related protein triggers adipose tissue browning and cancer cachexia","volume":"513","author":"Kir","year":"2014","journal-title":"Nature"},{"key":"B87","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1097\/SPC.0000000000000017","article-title":"Gut barrier dysfunction and microbial translocation in cancer cachexia: A new therapeutic target","volume":"7","author":"Klein","year":"2013","journal-title":"Curr. Opin. Support. Palliat. Care"},{"key":"B88","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1038\/s41416-021-01301-4","article-title":"Pancreatic cancer cachexia: Three dimensions of a complex syndrome","volume":"124","author":"Kordes","year":"2021","journal-title":"Br. J. Cancer"},{"key":"B89","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/S1470-2045(15)00027-3","article-title":"Metformin in patients with advanced pancreatic cancer: A double-blind, randomised, placebo-controlled phase 2 trial","volume":"16","author":"Kordes","year":"2015","journal-title":"Lancet. Oncol."},{"key":"B90","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1097\/MCO.0b013e328351c3fc","article-title":"TWEAK and TRAF6 regulate skeletal muscle atrophy","volume":"15","author":"Kumar","year":"2012","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"B91","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.devcel.2015.02.012","article-title":"Systemic organ wasting induced by localized expression of the secreted Insulin\/IGF antagonist ImpL2","volume":"33","author":"Kwon","year":"2015","journal-title":"Dev. Cell"},{"key":"B92","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1093\/annonc\/mdx349","article-title":"Treating cancer cachexia: An evolving landscape","volume":"28","author":"Laird","year":"2017","journal-title":"Ann. Oncol."},{"key":"B93","doi-asserted-by":"publisher","first-page":"5456","DOI":"10.1158\/1078-0432.CCR-13-1066","article-title":"Prognostic factors in patients with advanced cancer: A comparison of clinicopathological factors and the development of an inflammation-based prognostic system","volume":"19","author":"Laird","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"B94","doi-asserted-by":"crossref","DOI":"10.1007\/s10753-021-01429-8","article-title":"The emerging role of interleukin 1\u03b2 (IL-1\u03b2) in cancer cachexia","author":"Laird","year":"2021"},{"key":"B95","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s10741-016-9593-0","article-title":"Skeletal muscle inflammation and atrophy in heart failure","volume":"22","author":"Lavine","year":"2017","journal-title":"Heart fail. Rev."},{"key":"B96","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1016\/0026-0495(95)90040-3","article-title":"Negative impact of cancer chemotherapy on protein metabolism in healthy and tumor-bearing rats","volume":"44","author":"Le Bricon","year":"1995","journal-title":"Metabolism."},{"key":"B97","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1002\/jcsm.12077","article-title":"MAP3K11\/GDF15 axis is a critical driver of cancer cachexia","volume":"7","author":"Lerner","year":"2015","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"B98","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.3945\/ajcn.2008.27273","article-title":"A viscerally driven cachexia syndrome in patients with advanced colorectal cancer: Contributions of organ and tumor mass to whole-body energy demands","volume":"89","author":"Lieffers","year":"2009","journal-title":"Am. J. Clin. Nutr."},{"key":"B99","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.cell.2020.11.034","article-title":"Hallmarks of health\u201d","volume":"184","author":"L\u00f3pez-Ot\u00edn","year":"2021","journal-title":"Cell"},{"key":"B100","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1002\/jcsm.12209","article-title":"Circulating Activin A predicts survival in cancer patients","volume":"8","author":"Loumaye","year":"2017","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"B101","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1016\/j.clinbiochem.2017.07.011","article-title":"Biomarkers of cancer cachexia","volume":"50","author":"Loumaye","year":"2017","journal-title":"Clin. Biochem."},{"key":"B102","doi-asserted-by":"publisher","first-page":"2699","DOI":"10.1158\/1078-0432.CCR-06-2720","article-title":"Insulin treatment in cancer cachexia: Effects on survival, metabolism, and physical functioning","volume":"13","author":"Lundholm","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"B103","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.3389\/fimmu.2018.01145","article-title":"Disease-associated particulates and joint inflammation; mechanistic insights and potential therapeutic targets","volume":"9","author":"Mahon","year":"2018","journal-title":"Front. Immunol."},{"key":"B104","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.jviscsurg.2017.10.007","article-title":"Risk factors of exocrine and endocrine pancreatic insufficiency after pancreatic resection: A multi-center prospective study","volume":"155","author":"Maignan","year":"2018","journal-title":"J. Visc. Surg."},{"key":"B105","doi-asserted-by":"publisher","first-page":"5802","DOI":"10.1158\/1078-0432.CCR-05-0185","article-title":"Role of mononuclear cells and inflammatory cytokines in pancreatic cancer-related cachexia","volume":"11","author":"Martignoni","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"B106","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1002\/jcsm.12939","article-title":"Hypothalamic-pituitary-adrenal axis activation and glucocorticoid-responsive gene expression in skeletal muscle and liver of Apc mice","volume":"13","author":"Martin","year":"2022","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"B107","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s43440-020-00179-y","article-title":"Altered glucose metabolism and insulin resistance in cancer-induced cachexia: A sweet poison","volume":"73","author":"Masi","year":"2021","journal-title":"Pharmacol. Rep."},{"key":"B108","doi-asserted-by":"publisher","first-page":"2379","DOI":"10.1152\/japplphysiol.00778.2005","article-title":"Myofiber degeneration\/regeneration is induced in the cachectic ApcMin\/+ mouse.","volume":"99","author":"Mehl","year":"2005","journal-title":"J. Appl. Physiol."},{"key":"B109","doi-asserted-by":"publisher","first-page":"761","DOI":"10.3390\/nu13030761","article-title":"Sarcopenia, malnutrition, and cachexia: Adapting definitions and terminology of nutritional disorders in older people with cancer","volume":"13","author":"Meza-Valderrama","year":"2021","journal-title":"Nutrients"},{"key":"B110","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1200\/JCO.2005.04.2838","article-title":"Assessment of tumor necrosis factor alpha blockade as an intervention to improve tolerability of dose-intensive chemotherapy in cancer patients","volume":"24","author":"Monk","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"B111","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1002\/jcsm.12626","article-title":"High levels of modified ceramides are a defining feature of murine and human cancer cachexia","volume":"11","author":"Morigny","year":"2020","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"B112","first-page":"331","article-title":"Diabetes and pancreatic cancer","volume":"58","author":"Muniraj","year":"2012","journal-title":"Minerva Gastroenterol. Dietol."},{"key":"B113","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1097\/SPC.0000000000000091","article-title":"Role of interleukin-6 in cachexia: Therapeutic implications","volume":"8","author":"Narsale","year":"2014","journal-title":"Curr. Opin. Support. Palliat. Care"},{"key":"B114","doi-asserted-by":"publisher","first-page":"e0119888","DOI":"10.1371\/journal.pone.0119888","article-title":"Liver inflammation and metabolic signaling in ApcMin\/+ mice: The role of cachexia progression","volume":"10","author":"Narsale","year":"2015","journal-title":"PLoS ONE"},{"key":"B115","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1002\/jcsm.12424","article-title":"Cancer-driven changes link T cell frequency to muscle strength in people with cancer: A pilot study","volume":"10","author":"Narsale","year":"2019","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"B116","doi-asserted-by":"publisher","first-page":"E158","DOI":"10.1152\/ajpendo.00521.2018","article-title":"Gut bacteria are critical for optimal muscle function: A potential link with glucose homeostasis","volume":"317","author":"Nay","year":"2019","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"B117","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.5858\/arpa.2011-0521-OA","article-title":"Causes of death of patients with lung cancer","volume":"136","author":"Nichols","year":"2012","journal-title":"Arch. Pathol. Lab. Med."},{"key":"B118","doi-asserted-by":"publisher","first-page":"720096","DOI":"10.3389\/fcell.2021.720096","article-title":"Metabolic biomarkers for the early detection of cancer cachexia","volume":"9","author":"O\u2019Connell","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"B119","doi-asserted-by":"publisher","first-page":"453","DOI":"10.3892\/or.2012.1812","article-title":"Circulating myeloid-derived suppressor cells are increased and correlate to immune suppression, inflammation and hypoproteinemia in patients with cancer\u201d","volume":"28","author":"Ohki","year":"2012","journal-title":"Oncol. Rep."},{"key":"B120","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s40168-019-0704-8","article-title":"Macronutrient metabolism by the human gut microbiome: Major fermentation by-products and their impact on host health","volume":"7","author":"Oliphant","year":"2019","journal-title":"Microbiome"},{"key":"B121","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/1743-7075-9-76","article-title":"Theophylline is able to partially revert cachexia in tumour-bearing rats","volume":"9","author":"Olivan","year":"2012","journal-title":"Nutr. Metab."},{"key":"B122","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1186\/s12885-016-2424-9","article-title":"Metformin treatment modulates the tumour-induced wasting effects in muscle protein metabolism minimising the cachexia in tumour-bearing rats","volume":"16","author":"Oliveira","year":"2016","journal-title":"BMC Cancer"},{"key":"B123","doi-asserted-by":"publisher","first-page":"3990","DOI":"10.3390\/cancers13163990","article-title":"Neural mechanisms of cancer cachexia","volume":"13","author":"Olson","year":"","journal-title":"Cancers"},{"key":"B124","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1038\/s41467-021-22361-3","article-title":"Lipocalin 2 mediates appetite suppression during pancreatic cancer cachexia","volume":"12","author":"Olson","year":"","journal-title":"Nat. Commun."},{"key":"B125","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.lungcan.2011.09.012","article-title":"Pre-cachexia in patients with stages I-III non-small cell lung cancer: Systemic inflammation and functional impairment without activation of skeletal muscle ubiquitin proteasome system","volume":"76","author":"Op den Kamp","year":"2012","journal-title":"Lung Cancer"},{"key":"B126","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1002\/jcsm.12565","article-title":"The expression landscape of cachexia-inducing factors in human cancers","volume":"11","author":"Paccielli Freire","year":"2020","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"B127","doi-asserted-by":"publisher","first-page":"E1799","DOI":"10.3390\/cancers11111799","article-title":"Blocking Activin receptor ligands is not sufficient to rescue cancer-associated gut microbiota-A role for gut microbial flagellin in colorectal cancer and cachexia?","volume":"11","author":"Pekkala","year":"2019","journal-title":"Cancers"},{"key":"B128","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.semcdb.2015.09.002","article-title":"Experimental cancer cachexia: Evolving strategies for getting closer to the human scenario","volume":"54","author":"Penna","year":"2016","journal-title":"Semin. Cell Dev. Biol."},{"key":"B129","doi-asserted-by":"publisher","first-page":"963","DOI":"10.3390\/cancers14040963","article-title":"Early neutrophilia marked by aerobic glycolysis sustains host metabolism and delays cancer cachexia\u201d","volume":"14","author":"Petruzzelli","year":"2022","journal-title":"Cancers"},{"key":"B130","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.cmet.2014.06.011","article-title":"A switch from white to Brown fat increases energy expenditure in cancer-associated cachexia","volume":"20","author":"Petruzzelli","year":"2014","journal-title":"Cell Metab."},{"key":"B131","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.1038\/s41598-017-02088-2","article-title":"Cancer cachexia associates with a systemic autophagy-inducing activity mimicked by cancer cell-derived IL-6 trans-signaling","volume":"7","author":"Pettersen","year":"2017","journal-title":"Sci. Rep."},{"key":"B132","doi-asserted-by":"publisher","first-page":"e000042","DOI":"10.1136\/esmoopen-2016-000042","article-title":"Cancer and liver cirrhosis: Implications on prognosis and management","volume":"1","author":"Pinter","year":"2016","journal-title":"ESMO Open"},{"key":"B133","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1172\/JCI39920","article-title":"Acylated and unacylated ghrelin impair skeletal muscle atrophy in mice","volume":"123","author":"Porporato","year":"2013","journal-title":"J. Clin. Invest."},{"key":"B134","doi-asserted-by":"publisher","first-page":"e200","DOI":"10.1038\/oncsis.2016.3","article-title":"Understanding cachexia as a cancer metabolism syndrome","volume":"5","author":"Porporato","year":"2016","journal-title":"Oncogenesis"},{"key":"B135","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1038\/sj.bjc.6606087","article-title":"An inflammation-based prognostic score (mGPS) predicts cancer survival independent of tumour site: A glasgow inflammation outcome study","volume":"104","author":"Proctor","year":"2011","journal-title":"Br. J. Cancer"},{"key":"B136","volume-title":"Oncology update: Anamorelin\u201d,","author":"Prommer","year":"2017"},{"key":"B137","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1016\/J.BBADIS.2011.08.010","article-title":"Gut barrier dysfunction in the ApcMin\/+ mouse model of colon cancer cachexia","volume":"1812","author":"Puppa","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"B138","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1126\/science.2296722","article-title":"A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse","volume":"247","author":"Rapaich Moser","year":"1990","journal-title":"Science"},{"key":"B139","doi-asserted-by":"publisher","first-page":"7622","DOI":"10.1200\/jco.2010.28.15_suppl.7622","article-title":"Efect of ALD518, a humanized anti-IL-6 antibody, on lean body mass loss and symptoms in patients with advanced non-small cell lung cancer (NSCLC): Results of a phase II randomized, double-blind safety and efficacy trial","volume":"28","author":"Rigas","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"B140","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/jcsm.12911","article-title":"Cancer cachexia: The elephant in the room?","volume":"13","author":"Roeland","year":"2021","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"B141","doi-asserted-by":"publisher","first-page":"E7841","DOI":"10.3390\/ijms21217841","article-title":"Mitochondrial function and protein turnover in the diaphragm are altered in LLC tumor model of cancer cachexia","volume":"21","author":"Rosa-Caldwell","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B142","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1139\/apnm-2019-0407","article-title":"Hepatic alterations during the development and progression of cancer cachexia","volume":"45","author":"Rosa-Caldwell","year":"2019","journal-title":"Appl. Physiol. Nutr. Metab."},{"key":"B143","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/nrgastro.2013.49","article-title":"New insights into pancreatic cancer-induced paraneoplastic diabetes","volume":"10","author":"Sah","year":"2013","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B144","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/sj.bjc.6602725","article-title":"Angiotensin II directly induces muscle protein catabolism through the ubiquitin-proteasome proteolytic pathway and may play a role in cancer cachexia","volume":"93","author":"Sanders","year":"2005","journal-title":"Br. J. Cancer"},{"key":"B145","doi-asserted-by":"publisher","first-page":"E1004","DOI":"10.3390\/cancers12041004","article-title":"The emerging role of MicroRNAs and other non-coding RNAs in cancer cachexia","volume":"12","author":"Santos","year":"2020","journal-title":"Cancers"},{"key":"B146","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/s41467-020-20123-1","article-title":"Mechanisms of muscle atrophy and hypertrophy: Implications in health and disease","volume":"12","author":"Sartori","year":"2021","journal-title":"Nat. Commun."},{"key":"B147","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.clnu.2011.07.010","article-title":"Is IL-6 the best pro-inflammatory biomarker of clinical outcomes of cancer cachexia?","volume":"31","author":"Scheede-Bergdahl","year":"2012","journal-title":"Clin. Nutr."},{"key":"B148","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1080\/15216549800201202","article-title":"Carnitine palmitoyltransferase ii activity is decreased in liver mitochondria of cachectic rats bearing the walker 256 carcinosarcoma: Effect of indomethacin treatment","volume":"44","author":"Seelaender","year":"1998","journal-title":"Biochem. Mol. Biol. Int."},{"key":"B149","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1038\/nrc2507","article-title":"Cytokines and their relationship to the symptoms and outcome of cancer.","volume":"8","author":"Seruga","year":"2008","journal-title":"Nat. Rev. Cancer"},{"key":"B150","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.canlet.2020.04.017","article-title":"Macrophages potentiate STAT3 signaling in skeletal muscles and regulate pancreatic cancer cachexia","volume":"484","author":"Shukla","year":"2020","journal-title":"Cancer Lett."},{"key":"B151","doi-asserted-by":"publisher","first-page":"554","DOI":"10.231\/JIM.0b013e3181cf91ca","article-title":"Adipokines in patients with cancer anorexia and cachexia","volume":"58","author":"Smiechowska","year":"2010","journal-title":"J. Investig. Med."},{"key":"B152","first-page":"410","article-title":"Calpain activity is increased in skeletal muscle from gastric cancer patients with no or minimal weight loss","volume-title":"Muscle Nerve","author":"Smith","year":"2011"},{"key":"B153","doi-asserted-by":"publisher","first-page":"C1947","DOI":"10.1152\/ajpcell.00269.2007","article-title":"IFN-gamma does not mimic the catabolic effects of TNF-alpha.","volume":"293","author":"Smith","year":"2007","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"B154","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.7150\/jca.50376","article-title":"GDF15\/GFRAL pathway as a metabolic signature for cachexia in patients with cancer","volume":"12","author":"Sohail Ahmed","year":"2021","journal-title":"J. Cancer"},{"key":"B155","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.4049\/jimmunol.150.6.2341","article-title":"Mechanisms of experimental cancer cachexia. Local involvement of IL-1 in colon-26 tumor","volume":"150","author":"Strassmann","year":"1993","journal-title":"J. Immunol."},{"key":"B156","doi-asserted-by":"publisher","first-page":"002176","DOI":"10.1136\/bmjspcare-2019-002176","article-title":"Cachexia is associated with depression, anxiety and quality of life in cancer patients","volume":"2019","author":"Sun","year":"2020","journal-title":"BMJ Support. Palliat. Care"},{"key":"B157","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1038\/s41591-020-0945-x","article-title":"Antibody-mediated inhibition of GDF15-GFRAL activity reverses cancer cachexia in mice","volume":"26","author":"Suriben","year":"2020","journal-title":"Nat. Med."},{"key":"B158","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1016\/j.celrep.2019.07.016","article-title":"Modeling human cancer-induced cachexia","volume":"28","author":"Talbert","year":"2019","journal-title":"Cell Rep."},{"key":"B159","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.trecan.2022.01.004","article-title":"Emerging signaling mediators in the anorexia\u2013cachexia syndrome of cancer","volume":"8","author":"Talbert","year":"2022","journal-title":"Trends Cancer"},{"key":"B160","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s13539-014-0141-2","article-title":"Modeling human cancer cachexia in colon 26 tumor-bearing adult mice","volume":"5","author":"Talbert","year":"2014","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"B161","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/S1470-2045(15)00558-6","article-title":"Anamorelin in patients with non-small-cell lung cancer and cachexia (ROMANA 1 and ROMANA 2): Results from two randomised, double-blind, phase 3 trials","volume":"17","author":"Temel","year":"2016","journal-title":"Lancet. Oncol."},{"key":"B162","doi-asserted-by":"publisher","first-page":"6389","DOI":"10.3390\/cancers13246389","article-title":"Bile acid dysregulation is intrinsically related to cachexia in tumor-bearing mice","volume":"13","author":"Thibaut","year":"2021","journal-title":"Cancers"},{"key":"B163","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1002\/jcsm.12652","article-title":"Inflammation-induced cholestasis in cancer cachexia","volume":"12","author":"Thibaut","year":"2020","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"B164","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.3892\/ijo.2011.1150","article-title":"Evidence for cardiac atrophic remodeling in cancer-induced cachexia in mice","volume":"39","author":"Tian","year":"2011","journal-title":"Int. J. Oncol."},{"key":"B165","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1152\/physrev.00016.2008","article-title":"Mechanisms of cancer cachexia","volume":"89","author":"Tisdale","year":"2009","journal-title":"Physiol. Rev."},{"key":"B166","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1093\/infdis\/157.3.413","article-title":"Cachectin: A hormone that triggers acute shock and chronic cachexia","volume":"157","author":"Tracey","year":"1988","journal-title":"J. Infect. Dis."},{"key":"B167","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s12904-019-0429-2","article-title":"A prospective study examining cachexia predictors in patients with incurable cancer","volume":"18","author":"Vagnildhaug","year":"2019","journal-title":"BMC Palliat. Care"},{"key":"B168","doi-asserted-by":"publisher","first-page":"11803","DOI":"10.18632\/oncotarget.7730","article-title":"Beneficial bacteria inhibit cachexia","volume":"7","author":"Varian","year":"2016","journal-title":"Oncotarget"},{"key":"B169","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1016\/j.clnu.2016.09.008","article-title":"Use of routinely available clinical, nutritional, and functional criteria to classify cachexia in advanced cancer patients","volume":"36","author":"Vigano","year":"2017","journal-title":"Clin. Nutr."},{"key":"B170","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/jcsm.12675","article-title":"The regulatory approval of anamorelin for treatment of cachexia in patients with non-small cell lung cancer, gastric cancer, pancreatic cancer, and colorectal cancer in Japan: Facts and numbers","volume":"12","author":"Wakabayashi","year":"2020","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"B171","doi-asserted-by":"publisher","first-page":"4676","DOI":"10.4049\/jimmunol.181.7.4676","article-title":"A novel role for CD4+ T cells in the control of cachexia","volume":"181","author":"Wang","year":"2008","journal-title":"J. Immunol."},{"key":"B172","first-page":"18","article-title":"A multicenter, phase II study of infliximab plus gemcitabine in pancreatic cancer cachexia","volume":"6","author":"Wiedenmann","year":"2008","journal-title":"J. Support. Oncol."},{"key":"B173","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1172\/JCI88880","article-title":"Skeletal muscle inflammation and insulin resistance in obesity","volume":"127","author":"Wu","year":"2017","journal-title":"J. Clin. Invest."},{"key":"B174","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1245\/s10434-012-2577-y","article-title":"Resolution of diabetes after pancreaticoduodenectomy in patients with and without pancreatic ductal cell adenocarcinoma","volume":"20","author":"Wu","year":"2013","journal-title":"Ann. Surg. Oncol."},{"key":"B175","doi-asserted-by":"publisher","first-page":"E8592","DOI":"10.3390\/ijms21228592","article-title":"Cachexia, a systemic disease beyond muscle atrophy","volume":"21","author":"Wyart","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B176","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1038\/s41556-020-00628-z","article-title":"Tumour-derived Dilp8\/INSL3 induces cancer anorexia by regulating feeding neuropeptides via Lgr3\/8 in the brain","volume":"23","author":"Yeom","year":"2021","journal-title":"Nat. Cell Biol."},{"key":"B177","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/s12276-022-00752-w","article-title":"Understanding the molecular basis of anorexia and tissue wasting in cancer cachexia","volume":"54","author":"Yeom","year":"2022","journal-title":"Exp. Mol. Med."},{"key":"B178","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1111\/j.1365-2613.2006.00477.x","article-title":"Developmental abnormalities in multiple proliferative tissues of Apc(Min\/+) mice","volume":"87","author":"You","year":"2006","journal-title":"Int. J. Exp. Pathol."},{"key":"B179","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/1471-2407-7-45","article-title":"Association of IL-1beta gene polymorphism with cachexia from locally advanced gastric cancer","volume":"7","author":"Zhang","year":"2007","journal-title":"BMC Cancer"},{"key":"B180","doi-asserted-by":"publisher","first-page":"19","DOI":"10.7243\/2049-7962-1-19","article-title":"Detection of bacterial DNA in serum from colon cancer patients: Association with cytokine levels and cachexia","volume":"1","author":"Zhang","year":"2012","journal-title":"J. Cancer Ther. Res."},{"key":"B181","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.cell.2010.07.011","article-title":"Reversal of cancer cachexia and muscle wasting by ActRIIB antagonism leads to prolonged survival","volume":"142","author":"Zhou","year":"2010","journal-title":"Cell"},{"key":"B182","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.semcdb.2016.02.009","article-title":"STAT3 in the systemic inflammation of cancer cachexia","volume":"54","author":"Zimmers","year":"2016","journal-title":"Semin. Cell Dev. Biol."},{"key":"B183","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.3389\/fonc.2020.01262","article-title":"Reduced LDL-cholesterol and reduced total cholesterol as potential indicators of early cancer in male treatment-na\u00efve cancer patients with pre-cachexia and cachexia","volume":"10","author":"Zwickl","year":"2020","journal-title":"Front. Oncol."}],"container-title":["Frontiers in Cell and Developmental Biology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2022.960341\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,18]],"date-time":"2023-02-18T07:16:36Z","timestamp":1676704596000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2022.960341\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,8]]},"references-count":183,"alternative-id":["10.3389\/fcell.2022.960341"],"URL":"https:\/\/doi.org\/10.3389\/fcell.2022.960341","relation":{},"ISSN":["2296-634X"],"issn-type":[{"value":"2296-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,8]]},"article-number":"960341"}}